Myeloid Sarcoma

cancer family

Identifier: CI-CAN-00000280
Entity page: /cancer/myeloid-sarcoma ↗
Edges: 47

Neighbours: 18 drugs13 trials
Drawn: 31 of 31 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Myeloid Sarcoma investigated for …INVESTIGATED_FOR8 of 8
← investigated for	Sorafenib Tosylatesmall_molecule	unknown	3	Myeloid Sarcoma	1	Curated	chembl	graph →
← investigated for	Sorafenibsmall_molecule	unknown	3

Myeloid Sarcoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 26show all (up to 200)
→ investigated in trials for	Cytarabinesmall_molecule 7 trials (3 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Melphalansmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Mitoxantronesmall_molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Thiotepasmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Cladribinesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Daunorubicinsmall_molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall_molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Rituximabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Venetoclaxsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Aldesleukinother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Asparaginaseother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Azacitidinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Blinatumomabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →

Myeloid Sarcoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 26show all (up to 200)

→ investigated in trials for

Cytarabinesmall_molecule

7 trials (3 active) · roll-up of the cancer and its descendants

—

Myeloid Sarcoma

Observed

Myeloid Sarcoma studied in …STUDIED_INderived13 of 13show fewer
→ studied in	NCT01371981Phase 3 · completed Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03589729Phase 2 · recruiting Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04797767Phase 1/Phase 2 · recruiting Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms · condition mapped CURATED_BROADER · 13 trials mapped (6 active)	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05735184Phase 1 · recruiting A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02790515Phase 2 · active not recruiting Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07028086Phase 2 · recruiting VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02658487Phase 2 · completed Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04521946Phase 1 · withdrawn Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Intracranial Myeloid Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02484391Phase 1 · completed CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Granulocytic Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05854966Phase 2 · withdrawn CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Granulocytic Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06111612recruiting Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02259348Phase 2 · terminated Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01621477Phase 2 · terminated T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant · condition mapped ONTOLOGY_EXACT · 13 trials mapped (6 active)	—	—	Myeloid Sarcoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains